Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.
2.

Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.

Walker GJ, Flores JF, Glendening JM, Lin AH, Markl ID, Fountain JW.

Genes Chromosomes Cancer. 1998 Jun;22(2):157-63. Review.

PMID:
9598804
3.

Replicative senescence as a barrier to human cancer.

Parkinson EK, Munro J, Steeghs K, Morrison V, Ireland H, Forsyth N, Fitzsimmons S, Bryce S.

Biochem Soc Trans. 2000 Feb;28(2):226-33. Review.

PMID:
10816133
4.

[The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].

Soufir N, Basset-Seguin N.

Bull Cancer. 2001 Nov;88(11):1061-7. Review. French.

5.

p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review.

Al-Kaabi A, van Bockel LW, Pothen AJ, Willems SM.

Dis Markers. 2014;2014:260549. doi: 10.1155/2014/260549. Epub 2014 Apr 7. Review.

6.

Genetic dissection of melanoma pathways in the mouse.

Yang FC, Merlino G, Chin L.

Semin Cancer Biol. 2001 Jun;11(3):261-8. Review.

PMID:
11407950
7.

Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.

Murthy SS, Testa JR.

J Cell Physiol. 1999 Aug;180(2):150-7. Review.

PMID:
10395284
8.

The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.

Ivanchuk SM, Mondal S, Dirks PB, Rutka JT.

J Neurooncol. 2001 Feb;51(3):219-29. Review.

PMID:
11407594
9.

[Cyclin-dependent kinase 4 inhibitor a and tumor].

Gong Z, Fu J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Jun;18(3):219-21. Review. Chinese.

PMID:
11402455
10.

The INK4a/ARF locus in murine tumorigenesis.

Serrano M.

Carcinogenesis. 2000 May;21(5):865-9. Review.

PMID:
10783305
11.

The INK4A/ARF locus and its two gene products.

Sharpless NE, DePinho RA.

Curr Opin Genet Dev. 1999 Feb;9(1):22-30. Review.

PMID:
10072356
12.

Alternative product of the p16/CKDN2A locus connects the Rb and p53 tumor suppressors.

James MC, Peters G.

Prog Cell Cycle Res. 2000;4:71-81. Review.

PMID:
10740816
13.

The physiology of p16(INK4A)-mediated G1 proliferative arrest.

Shapiro GI, Edwards CD, Rollins BJ.

Cell Biochem Biophys. 2000;33(2):189-97. Review.

PMID:
11325039
14.

SV40 and cell cycle perturbations in malignant mesothelioma.

Testa JR, Giordano A.

Semin Cancer Biol. 2001 Feb;11(1):31-8. Review.

PMID:
11243897
15.

p16(MTS-1/CDKN2/INK4a) in cancer progression.

Rocco JW, Sidransky D.

Exp Cell Res. 2001 Mar 10;264(1):42-55. Review.

PMID:
11237522
16.

Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor.

King TC, Estalilla OC, Safran H.

Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):4-11. Review.

PMID:
10210535
17.

Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme.

Solomon DA, Kim JS, Jean W, Waldman T.

Cancer Res. 2008 Nov 1;68(21):8657-60. doi: 10.1158/0008-5472.CAN-08-2084. Review.

18.

Methylation mechanisms in pituitary tumorigenesis.

Farrell WE, Simpson DJ, Frost SJ, Clayton RN.

Endocr Relat Cancer. 1999 Dec;6(4):437-47. Review.

19.

p16(INK4a)/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?

Pérez-Sayáns M, Suárez-Peñaranda JM, Gayoso-Diz P, Barros-Angueira F, Gándara-Rey JM, García-García A.

Cancer Lett. 2011 Jul 28;306(2):134-41. doi: 10.1016/j.canlet.2011.02.039. Epub 2011 Mar 15. Review.

PMID:
21411222
20.

Molecular diagnosis of pancreas carcinoma.

Chu TM.

J Clin Lab Anal. 1997;11(4):225-31. Review.

PMID:
9219065

Supplemental Content

Support Center